Luye Pharma Group Ltd.: all 94 studies

Page 1 of 1. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.

• A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1203 in Advanced Solid Tumors.RecruitingNCT07876609Phase 1
• Mass Balance Study of [14C] LPM3770164 in Healthy ParticipantsNot yet recruitingNCT07516899Phase 1
• A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With SchizophreniaNot yet recruitingNCT07396870Phase 2
• LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS MutationNot yet recruitingNCT07391566Phase 1/2
• To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese SubjectsEnrolling by invitationNCT07371065Phase 1
• A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020RecruitingNCT07230652Phase 1
• A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017Not yet recruitingNCT06980207Phase 1
• A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1301 in Advanced Solid Tumors.RecruitingNCT06927349Phase 1
• Effect of Food and Age on the Pharmacokinetics of LY03017Not yet recruitingNCT06793995Phase 1
• Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive DyskinesiaRecruitingNCT06731868Phase 1/2
• Safety and Efficacy of BA1302 in Patients With Advanced Solid TumorsRecruitingNCT06596915Phase 1
• Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLCRecruitingNCT06496048Phase 3
• Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Orthopedic SurgeryRecruitingNCT06467409Phase 2
• To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release TabletsNot yet recruitingNCT06426485Phase 4
• First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.RecruitingNCT06240546Phase 1
• Study of LY01610 in Patients With Recurrent Small Cell Lung CancerRecruitingNCT06128837Phase 3
• A Study of BA1202 in Patients With Advanced Solid TumorsRecruitingNCT05909241Phase 1
• Safety, Tolerability, Pharmacokinetics (PK), and Primary Clinical Efficacy of LY01616 in Patients With Advanced Solid TumorsEnrolling by invitationNCT05865925Phase 1/2
• Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mgNot yet recruitingNCT05856630Phase 1
• A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid TumorsRecruitingNCT05650242Phase 1
• A Study of LY03015 in Healthy Chinese and Caucasian Adult SubjectsCompletedNCT07671833Phase 1
• A Food Effect Study of LY03020 in Healthy SubjectsActive, not recruitingNCT07292233Phase 1
• Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)Active, not recruitingNCT07236476Phase 2
• A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy SubjectsCompletedNCT06556966Phase 1
• Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release TabletsCompletedNCT06474650Phase 1
• A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017Status unknownNCT06388551Phase 1
• Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy SubjectsCompletedNCT06216054Phase 1
• Phase II Clinical Trial to Evaluate the Efficacy and Safety of LPM3480392 Injection for Moderate to Severe Pain After Abdominal SurgeryCompletedNCT06204120Phase 2
• Comparing the Pharmacokinetic Profile of LY01612 and CAELYX® in Chinese Subjects With Advanced Breast CancerCompletedNCT06098599Phase 1
• A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous InjectionCompletedNCT06095427Phase 1
• A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell CarcinomaActive, not recruitingNCT06022861Phase 3
• A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.CompletedNCT05970510Phase 3
• A Dose-escalation Study of LPM3480392 in Chinese Healthy SubjectsCompletedNCT05862974Phase 1
• An Exploratory Study of LPM3480392 at Different Infusion Rates in Chinese Healthy SubjectsCompletedNCT05857449Phase 1
• Comparative Efficacy, Safety, PK, and Immunogenicity StudyActive, not recruitingNCT05853354Phase 3
• Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)CompletedNCT05853341Phase 1
• Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT05321602Phase 1
• A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy SubjectsCompletedNCT05238701Phase 1
• Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®CompletedNCT05140512Phase 1
• Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®CompletedNCT05110170Phase 3
• Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male SubjectsCompletedNCT05110118Phase 1
• A Study to Evaluate the Efficacy and Safety of LY06006 in Postmenopausal Women With Osteoporosis at High Risk for FractureStatus unknownNCT05060406Phase 3
• A Phase I Study of LY-CovMab Injection in Chinese Healthy SubjectsStatus unknownNCT04973735Phase 1
• A Study to Evaluate LY06006 and Prolia in Healthy AdultsStatus unknownNCT04973722Phase 1
• Relative Bioavailability of LY03010 Compared to Listed DrugCompletedNCT04922593Phase 1
• Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid TumorsStatus unknownNCT04859569Phase 3
• A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedNCT04853407Phase 3
• Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors PatientsCompletedNCT04638491Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PDCompletedNCT04630860Phase 1
• A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD PatientsCompletedNCT04629404Phase 1
• A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003CompletedNCT04627155Phase 1
• to Evaluate the Safety, Tolerability and Pharmacokinetics of Four Formulations of LY03009 in Healthy VolunteersStatus unknownNCT04593511Phase 1
• A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）Status unknownNCT04572698Phase 3
• Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia PatientsCompletedNCT04572685Phase 1
• A Study to Evaluate the Effectiveness and Safety of LY03003 in Patients With Early Primary PDCompletedNCT04571164Phase 3
• Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®CompletedNCT04563936Phase 3
• A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetic Profiles of Rotigotine After a Single Dose of LY03003 (28 mg) Versus After a Week of Daily NEUPRO® Transdermal Patch (4 mg Every 24 Hours) in Healthy VolunteersCompletedNCT04384666Phase 1
• Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung CancerCompletedNCT04381910Phase 2
• A Study to Evaluate LY01011 and Xgeva® in Healthy AdultsStatus unknownNCT04198636Phase 1
• Irinotecan Hydrochloride Liposome Injection (LY01610) For Advanced Solid TumorsCompletedNCT04088604Phase 1
• A Multiple Ascending Dose Study With LY03003 in Patients With Early-stage Parkinson's DiseaseCompletedNCT04045678Phase 1
• A Study of LY03003 in Patients With Early-stage Parkinson's DiseaseCompletedNCT04044547Phase 1
• A Study Evaluating the Safety, Tolerability of LPM3480226 Tablets in Patients With Advanced Solid TumorsStatus unknownNCT03844438Phase 1
• A Relative Bioavailability Food Effect Study of LY03005CompletedNCT03822065Phase 1
• Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedNCT03785652Phase 1
• A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia PatientsCompletedNCT03751488Phase 1
• A Study of LY03005 vs PristiqCompletedNCT03733574Phase 1
• A Study to Assess Pharmacokinetic Profiles of LY03003 and NeuproCompletedNCT03733561Phase 1
• Pharmacokinetic Study of LY03003 in Patients With Parkinson's DiseaseCompletedNCT03589066Phase 1
• A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung CancerStatus unknownNCT03533127Phase 3
• A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate CancerCompletedNCT03450109Phase 1
• A Study to Evaluate the Denosumab in Healthy AdultsStatus unknownNCT03427853Phase 1
• Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®CompletedNCT03357796Phase 1
• Paclitaxel Liposome for Squamous Non-Small-cell Lung Cancer Study(LIPUSU)Status unknownNCT02996214Phase 4
• Pilot BA Study of New LY03005 vs PristiqCompletedNCT02988024Phase 1
• Pharmacokinetic Profile of Neupro Patch Administrated at 2 mg, 4 mg, 6 mg and 8 mg/Day Weekly in Patients With Early-stage Parkinson's DiseaseCompletedNCT02728947Phase 1
• Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male VolunteersCompletedNCT02603770Phase 1
• Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005CompletedNCT02271412Phase 1
• An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT02186769Phase 1
• Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast CancerStatus unknownNCT02142790Phase 4
• Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast CancerStatus unknownNCT02142010Not applicable
• Bioavailability of LY03004 and Risperdal® Consta®CompletedNCT02091388Phase 1
• Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic LeukemiaStatus unknownNCT02072785Phase 3
• Safety, Tolerability and Pharmacokinetics Study of LY03005CompletedNCT02055300Phase 1
• Pharmacokinetic and Safety Study of LY03004 in Stable Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT02055287Phase 1
• Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's DiseaseCompletedNCT02055274Phase 1
• Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional TreatmentsStatus unknownNCT01994031Phase 4
• Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's DiseaseStatus unknownNCT01282619Phase 2/3
• Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric CarcinomaStatus unknownNCT00881816Phase 1
• Clinical Study of Liposomal Paclitaxel in Chinese PatientsStatus unknownNCT00881101Phase 1
• A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous CarcinomaStatus unknownNCT00642239Phase 4
• Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric CarcinomaStatus unknownNCT00639522Phase 1
• China Cimicifuga Trial of Climacteric Complaint ControlStatus unknownNCT00622986Phase 4
• Pharmacokinetics Study of Liposomal Paclitaxel in HumansCompletedNCT00606515Phase 4

← Luye Pharma Group Ltd. overview and focus areas